Testing effectiveness (Phase 2)Looking for participantsNCT06776848
What this trial is testing
A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With TBR1-related Neurocognitive Disorder
Who this might be right for
Proven Pathogenic or Probably Pathogenic TBR1 Variant
Centre Hospitalier Universitaire Dijon 12